Mitochondrial dysfunction: the engine problem behind aging
How mitochondrial decline drives the hallmarks of aging, and which interventions target it directly.
Mitochondria are not just batteries
The textbook description of mitochondria as “the powerhouse of the cell” understates their role. Mitochondria regulate apoptosis (programmed cell death), calcium signaling, immune activation, and epigenetic modifications. When mitochondrial function declines, the downstream effects cascade across nearly every system in the body.
This is why mitochondrial dysfunction appears in the Lopez-Otin hallmarks of aging (2013, updated 2023) and why researchers increasingly view it as an upstream driver rather than a passive consequence of aging.
How mitochondria decline with age
Several interconnected processes drive mitochondrial aging:
mtDNA mutations accumulate. Mitochondria have their own genome, which lacks the robust repair mechanisms of nuclear DNA. Over decades, mutations accumulate, impairing the electron transport chain.
Mitophagy slows. The process of clearing damaged mitochondria (mitophagy) becomes less efficient with age. Damaged mitochondria persist, producing excess reactive oxygen species.
NAD+ depletion. Mitochondrial function depends on NAD+ as an electron carrier. Declining NAD+ directly impairs oxidative phosphorylation.
Fusion-fission imbalance. Healthy mitochondria constantly fuse and divide to maintain quality. Aging shifts this balance, leading to fragmented, dysfunctional mitochondrial networks.
Interventions that target mitochondria
Exercise: The single most proven mitochondrial intervention. Both endurance (zone 2) and high-intensity interval training stimulate mitochondrial biogenesis through PGC-1alpha activation. Exercise also upregulates mitophagy.
Caloric restriction and fasting: Activates AMPK and sirtuins, both of which promote mitochondrial quality control. Time-restricted eating may provide similar signaling.
NAD+ precursors (NMN/NR): Restore NAD+ levels, supporting electron transport chain function. Evidence is mechanistically strong, clinically early.
Urolithin A: Stimulates mitophagy specifically. The Amazentis/Mitopure trials showed improved muscle endurance in older adults. One of the more promising targeted mitochondrial compounds.
CoQ10/Ubiquinol: Direct electron transport chain support. Evidence is mixed but may benefit people with documented CoQ10 deficiency, which increases with statin use and age.
What does not work (yet)
Antioxidant megadosing. The “mitochondria produce free radicals, so take antioxidants” logic has not held up. Reactive oxygen species serve important signaling functions, and suppressing them with high-dose vitamin C or E may actually impair mitochondrial adaptation to exercise.
MitoQ and other mitochondria-targeted antioxidants have shown some promise in animal models but human evidence remains limited and inconsistent.
Framework for thinking about mitochondrial health
Rather than chasing individual supplements, the evidence supports a hierarchy: exercise first (non-negotiable), metabolic health second (maintain insulin sensitivity, avoid chronic overfeeding), and targeted compounds third (NAD+ precursors, urolithin A) for those who want to optimize further.